Background: The majority of patients with head and neck cancer die of locoregional
rescurrence of disease following surgery and/or radiotherapy. Purpose: Our purpose was to …

Between May 1981 and December 1987, 152 consecutive patients with locally advanced
and previously untreated head and neck squamous cell cancer (HNSCC) received two or …

Thirty-five consecutive patients with primary unresectable head and neck cancers were
considered eligible for protocol treatment with neoadjuvant intraarterial cisplatin. External …

Abstract Between May 1981 and January 1986, 130 consecutive patients with advanced
untreated head and neck squamous cell cancer (HNSCC) received neoadjuvant …

From March 1983 to June 1986, 100 patients with locally advanced squamous cell
carcinoma of the head and neck were randomized to receive either two courses of …

One hundred fifteen consecutive patients with locally advanced carcinoma of the head and
neck were treated between August 1984 and August 1989 with three cycles of either of two …

A consecutive series of 22 patients with multiple synchronous squamous cell carcinomas of
the upper aerodigestive tract was retrospectively reviewed. These patients were treated …

• We treated 94 patients with advanced head and neck cancer with a combined-modality
protocol that included induction chemotherapy followed by surgery with and without …

Sixty‐six patients with locally advanced (Stages III and IV) carcinoma of the head and neck
were treated with three cycles of induction chemotherapy, consisting of cisplatin, fluorouracil …

Squamous cell carcinoma is the most common histologic type of cancer to involve in the
upper aerodigestive tract. Squamous cell carcinoma of the head and neck (SCCHN) is the …